niaprazine

Known as: N-(3-(4-(4-fluorophenyl)-1-piperazinyl)- 1-methylpropyl)-3-pyridinecarboxamide 
 
National Institutes of Health

Topic mentions per year

Topic mentions per year

1971-2017
01219712017

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2002
Review
2002
Insomnia in children is a nonspecific impairing symptom that may be the result of normal developmental changes, psychosocial… (More)
Is this relevant?
1999
1999
Niaprazine is a histamine H1-receptor antagonist with marked sedative properties. It has been employed in subjects with behavior… (More)
Is this relevant?
1996
1996
 
Is this relevant?
1991
1991
A placebo-controlled double-blind clinical trial on the effect of niaprazine on children with some common sleep disorders was… (More)
  • table 1
  • table 2
  • table 3
  • table 4
Is this relevant?
1988
1988
1. The pharmacological profile of niaprazine was investigated using in vitro ligand binding techniques. 2. Niaprazine exhibits a… (More)
Is this relevant?
1987
1987
The results of a randomized, double blind clinical trial are described. Niaprazine (1.5 mg/kg/day) or placebo were administered… (More)
Is this relevant?
1982
1982
Niaprazine (60 mg/kg i.p.) increased rat brain 5-hydroxyindole acetic acid (5-HIAA) concentrations 30 min after treatment, and… (More)
Is this relevant?